Company News: Johnson & Johnson (JNJ) quarterly results beat analysts’ expectations

Market news

17 July 2018

Company News: Johnson & Johnson (JNJ) quarterly results beat analysts’ expectations

Johnson & Johnson (JNJ) reported Q2 FY 2018 earnings of $2.10 per share (versus $1.83 in Q2 FY 2017), beating analysts' consensus estimate of $2.07.

The company's quarterly revenues amounted to $20.830 bln (+10.6% y/y), beating analysts' consensus estimate of $20.390 bln.

The company also issued guidance for FY 2018, narrowing EPS of $8.07-8.17 to $8.00-8.20 (versus analysts' consensus estimate of $8.12) and lowering revenues to $80.5-81.3 bln from $81.0-81.8 bln (versus analysts' consensus estimate of $81.37 bln).

JNJ fell to $123.10 (-1.28%) in pre-market trading.

UK will be leaving EU customs union; Brexit vote 'legitimate democratic exercise': Govt spokesman - Bloomberg

Company News: UnitedHealth (UNH) quarterly earnings beat analysts’ forecast

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.